KAG-308
Kategoria produktu: Biznes i przemysł > Badania naukowe i laboratoryjne
Sprzedawca:Gentaur
KAG-308 is a potent selective and orally active agonist of EP4 receptor (a prostaglandin E2 receptor subtype), suppresses colitis and promotes histological mucosal healing, potently inhibits TNF-α production. KAG-308 shows a Ki and an EC50 of 2.57 nM and 17 nM for human EP4 receptor, respectively, more selective over EP1, EP2, EP3 and IP receptor[1].
Specyfikacja/Zawartość:
- CAS number: 1215192-68-9
- Purity: 99.88
- Formula: C24H30F2N4O3
- Solubility: |DMSO : 80 mg/mL (ultrasonic)
- SMILES: O[C@H](C1)[C@H](/C=C/[C@@H](O)[C@@H](C2=CC=CC(C)=C2)C)[C@](C/3(F)F)([H])[C@@]1([H])OC3=C/CCCC4=NN=NN4
- Molecular Weight: 460.52
- Applications: COVID-19-immunoregulation
Wysyłka i przechowywanie:
-20°C (Powder, stored under nitrogen)
Inne:
For research use only. Not to be used for human or animal treatment or consumption.
0 opinie o KAG-308